Intellipharmaceutics International Inc. (IPCI)

[Amigo Mike]

Mopar,

Apparently IPCI is still questioning being CFP in 3Q as evidenced by the quote from the PR today.

There can be no assurance that the Company's generic Seroquel XR® in any of the 50, 150, 200, 300 and 400 mg strengths will be successfully commercialized.

ROFLMAO ...... announcing commercial launch is the topic of the PR .... yet ..... IPCI still isn't sure ..... LOLOLOLOLOLOL. Of course they do use the word "successful" but .... really ??? Come on !!!

Also pay close attention to the revenue numbers eh ?? As I have been telling everyone for a long time.
Seroquel annual revenues - IPCI PR 10/7/16 == >$1.2 billion
Seroquel annual revenues - IPCI PR TODAY == >$842 million
A decline of roughly 1/3rd in market size just over 8 months time. They will continue lower overall as more players enter and divy up market share. Will have to see where the annual revenue number settles out.

This is why generics don't get premium valuation and you have to have a long and strong pipeline to get valuation adjustments.

Amigo Mike